Also in this playlist...
This transcript is automatically generated
It's well this time now for the tech everybody David -- might -- -- -- president chief investment strategist -- back here on sat.
You like clothes not the -- -- though -- like the other -- It's absolutely I mean we you're listening to Warren -- a couple months ago when you talk about the best metric for these financial conglomerates -- book value is -- if the book value for his coverage it's still cheaper they'd be buying back shares so we went and looked at all the similar type conglomerates we came upon load which is some.
Times called the poor man's Berkshire Hathaway is -- about 39 dollars a share has a nice diversity of asset CNA insurance.
Diamond offshore and -- -- pipe.
-- Atlanta energy but kind of a mix of everything exactly out and if you value the -- -- Fifty dollars a share to you can buy that nice diversified portfolio for twenty -- evidently you like almost because the stock really hasn't been.
Substantial performer -- to say over the last year six months it if you look at for dividends is not the place to go about it Tisch family has wrong that operate for the last fifteen years.
In the total return per year for the last fifty years sixteen point 7% I'll give but I committed to any day for that -- eighty overturn okay you also like Novartis.
I find this interesting because this is a European name it is you know and it has been -- down 20% since the last make -- -- -- -- -- when you look at its operations.
It's -- -- 190 countries around the world more than two thirds their bid to sits outside with Novartis you basically have the J&J V Europe but -- valuation -- -- like the Pfizer valuation.
But only half of its assets are proprietary drug you've got nice steady Eddie businesses consumer Staples -- said print.
Sandoz which is year's second largest generic which is not.
It is so exposed to the.
Just saying it was not the department some of the business isn't a big concern for you because only a half of the exactly that -- percent of the business like on -- -- -- I'd like Johnson & Johnson a very good point.
OK let's move on to your last one in his -- -- we're talking about earlier with Nicole let's BP.
Curious what you fed your -- in the stock today evident -- we think about the fact it looks like we're getting towards at some point -- billion dollar settlement.
BP I mean if given day it looks like they're total cost for that -- spill is going to be a lot less from the money -- set aside.
So you don't get -- -- on the stock price is still 20% below was before this bill.
You know it's one of the cheapest energy companies out there and what we don't like what happened at the end of the day when you go to fill up your car you see the Exxon station exceeded BP you've -- BP gas is fifty cents last year when you go and what we do anything less a different in the stock -- cheaper.
And -- flooded data -- -- you up mentor president David thank you.
Interesting plex alright.
Filter by section